Jun Su, Richard A. Brook, Nathan L. Kleinman, Patricia Corey‐Lisle – 23 July 2010 – Chronic hepatitis C virus (HCV) infection is generally considered an asymptomatic disease. However, studies have shown that HCV has a substantial negative impact on patients' quality of life and functioning. This study was designed to compare absenteeism, productivity, and health cost between employees with and without HCV infection in the United States.

Paul A. Sharp – 23 July 2010

Robert J. Fontana, Leonard B. Seeff, Raúl J. Andrade, Einar Björnsson, Christopher P. Day, Jose Serrano, Jay H. Hoofnagle – 23 July 2010 – Idiosyncratic drug‐induced liver injury (DILI) is an important but relatively infrequent cause of potentially severe acute and chronic liver injury. The aim of this clinical research workshop was to review and attempt to standardize the current nomenclature and terminology used in DILI research.

Björn Lindkvist, Maria Benito de Valle, Bo Gullberg, Einar Björnsson – 23 July 2010 – Population‐based studies on the epidemiology of primary sclerosing cholangitis (PSC) are sparse. The aim of the present study was to investigate prevalence and temporal trends in the incidence of PSC 1992‐2005 in an adult population in Västra Götaland, a region in southern Sweden with a defined population of about 1.5 million. Patients with PSC aged 18 years or above were identified through a computerized search for diagnostic codes.

Susie A. Lee, Sara Ladu, Matthias Evert, Frank Dombrowski, Valentina De Murtas, Xin Chen, Diego F. Calvisi – 23 July 2010 – Sprouty2 (Spry2), a negative feedback regulator of the Ras/mitogen‐activated protein kinase (MAPK) pathway, is frequently down‐regulated in human hepatocellular carcinoma (HCC). We tested the hypothesis that loss of Spry2 cooperates with unconstrained activation of the c‐Met protooncogene to induce hepatocarcinogenesis via in vitro and in vivo approaches.

Jannes Woudenberg, Krzysztof P. Rembacz, Mark Hoekstra, Antonella Pellicoro, Fiona A. J. van den Heuvel, Janette Heegsma, Sven C. D. van IJzendoorn, Andreas Holzinger, Tsuneo Imanaka, Han Moshage, Klaas Nico Faber – 23 July 2010 – Peroxisomes are particularly abundant in the liver and are involved in bile salt synthesis and fatty acid metabolism.

Keigo Machida, Hidekazu Tsukamoto, Jian‐Chang Liu, Yuan‐Ping Han, Sugantha Govindarajan, Michael M. C. Lai, Shizuo Akira, Jing‐hsiung James Ou – 23 July 2010 – Hepatocellular carcinoma (HCC) occurs in a significant number of patients with hepatitis C virus (HCV) infection. HCV causes double‐strand DNA breaks and enhances the mutation frequency of proto‐oncogenes and tumor suppressors. However, the underlying mechanisms for these oncogenic events are still elusive.

Chang Han, William C. Bowen, Guiying Li, Anthony J. Demetris, George K. Michalopoulos, Tong Wu – 23 July 2010 – Hepatocellular carcinoma often develops in the setting of abnormal hepatocyte growth associated with chronic hepatitis and liver cirrhosis. Transforming growth factor β (TGF‐β) is a multifunctional cytokine pivotal in the regulation of hepatic cell growth, differentiation, migration, extracellular matrix production, stem cell homeostasis, and hepatocarcinogenesis. However, the mechanisms by which TGF‐β influences hepatic cell functions remain incompletely defined.

Rabin Rahmani, Elena Ivanina, Lina Yang – 23 July 2010

Kshaunish Das, Abhijit Chowdhury – 23 July 2010